ResearcherUniversity of CopenhagenActive in the last 2 years
Rasmus S. Pedersen
Matched on ORCID iD 0000-0003-2965-166X; OpenAlex author ID A5012651970. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers
Papers 4
- BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic target. Co-author DOI 10.1038/s41598-025-24463-0↗
- Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ducta… Co-author DOI 10.1186/s12885-025-14283-w↗
- Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibro… Co-author DOI 10.3390/biom12091315↗
- Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14030819↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- M.A. Karsdal · 4 shared papers, 2022–2025 · strength 0.72
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers14030819↗
- Nicholas Willumsen · 4 shared papers, 2022–2025 · strength 0.72
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers14030819↗
- Julia Sidenius Johansen · 4 shared papers, 2022–2025 · strength 0.72
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers14030819↗
- Inna Markovna Chen · 4 shared papers, 2022–2025 · strength 0.72
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers14030819↗
- Lars Nannestad Jørgensen · 3 shared papers, 2022–2025 · strength 0.56
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarci… DOI 10.3390/biom12091315↗
- Hadi M. H. Diab · 3 shared papers, 2022–2025 · strength 0.56
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarci… DOI 10.3390/biom12091315↗
- Carsten Palnæs Hansen · 3 shared papers, 2022–2025 · strength 0.53
- Paper Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in… DOI 10.1186/s12885-025-14283-w↗
- Paper Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers14030819↗
- Paper Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarci… DOI 10.3390/biom12091315↗
- Neel Ingemann Nissen · 3 shared papers, 2022–2025 · strength 0.49
- Paper BIGH3 is a mediator of TGFβ-Induced collagen formation in fibrosis and pancreatic cancer and a potential therapeutic ta… DOI 10.1038/s41598-025-24463-0↗
- Paper Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adeno… DOI 10.3390/cancers14030819↗
- Paper Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarci… DOI 10.3390/biom12091315↗
- Astrid Zedlitz Johansen · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.